With its lead gene therapy nearing the clinic, SwanBio leans heavily on Syncona to close $56M series B
https://www.fiercebiotech.com/biotech/its-lead-gene-therapy-nearing-clinic-swanbio-leans-heavily-syncona-close-56m-series-b
Medical Innovation Exchange @ Copywrite 2021. All Rights Reserved.